Objectives: The aim of this study was to investigate whether the sulphonamide resistance gene sul2 could be transferred between Escherichia coli in the human gut.
Introduction
Endogenous bacterial flora may play an important role as acceptor and donor of transmissible drug resistance genes. Escherichia coli is commonly found as a commensal in the intestinal tract, but may also be implicated in intestinal and extra-intestinal infections. Sulfamethizole is one of the first treatments of choice for uncomplicated urinary tract infections in Denmark. 1 The sul2 gene encodes sulphonamide resistance and is the most common gene found among sulphonamide-resistant E. coli from different animals, food, healthy humans and human infections. 2 -8 Resistance to sulphonamides caused by sul1 and sul2 was shown to be common among normal faecal flora E. coli of healthy fattening pigs in 10 herds with different antimicrobial use. 9, 10 The highest number of antimicrobial-resistant E. coli was from herds with a high use of antimicrobial agents. Non-pathogenic E. coli from pigs may thus represent a considerable reservoir of antimicrobial resistance genes that might be transferable to pathogens.
There have been numerous studies of resistance transfer in vitro, but few studies in vivo in humans. In vitro transfer of resistance genes is relatively easy to demonstrate and in vivo transfer in the intestine of germ-free or antibiotic-treated experimental animals has also been shown to occur. 11 -14 These transfers have been attained by modifying the normal flora of the intestinal tract.
There are very few reports of antimicrobial resistance transfer in man. In 1969, Smith 15 carried out an experiment in which antibiotic resistance (R factors) was transferred to the resident E. coli in the gut of a human from ingested cultures of E. coli of animal and human origins. The amount of transfer was small and the resistant resident organisms did not persist in the gut for long. In 1970, Wiedemann et al. 16 failed to demonstrate in vivo transmission of drug resistance from an E. coli to other enterobacteria in the gut of four human subjects.
There are several previous studies where antimicrobial agents were administered in parallel to the administration of E. coli strains to study their colonization and transfer in the gut. In 1974, Burton et al. 17 showed that the oral administration of tetracycline enhanced the colonization and the transfer of antibiotic resistance from an ingested E. coli of animal origin to the resident E. coli in the intestinal tract of humans. Transfer of the bla TEM-1b gene between two strains co-residing in the gut of a child treated with ampicillin was also demonstrated. 18 In vivo inter-bacterial transfer of the R factor was observed in two patients. It was transferred from E. coli in the gut of two patients to a Shigella sonnei and a Proteus mirabilis, respectively. 19 Indications of transfer of antimicrobial resistance in clinical cases have been observed, but controlled experiments with healthy humans showing transfer of resistance genes between E. coli under natural conditions are rare and not recent.
Some of the above-mentioned studies were published many years ago, before genotyping was widely available. The results of such studies should be viewed within the limits of their experimental design. Since we had the possibilities of using the latest molecular typing techniques, this is one of the methodological strengths of our study and our human model can assess with certainty if transfer of resistance genes has taken place.
The objective of this study was to investigate whether the sulphonamide resistance gene sul2 could transfer the human gut between E. coli bacteria; either from a pig-derived sulphonamide-resistant E. coli to a recipient of human origin provided, which would shed light on the risk associated with resistant E. coli in the food, or from E. coli in the resident flora to the recipient. As a side observation, the study also allowed us to measure to what extent a pig-derived E. coli could colonize the human gut and for how long. Such data are necessary to perform risk assessment of human intake of food containing resistant bacteria.
Materials and methods

Study subjects
The study was conducted with nine healthy human volunteers from February 2007 to February 2008. All were older than 18 years with normal intestinal functions. None had consumed antimicrobial agents 1 month prior to or during the study, and none took other medicines during the experiment. All volunteers were enlisted on an informed written consent basis. The study protocol for the healthy volunteers participating in this study was approved by the Scientific Ethics Committee for Copenhagen and Frederiksberg municipalities [(KF)01-324866].
Bacterial strains
The donor strain was an E. coli of animal origin, isolated from a Danish healthy pig in 2003. 20 It was resistant to sulphonamides (MIC .1024 mg/L) and gentamicin (MIC .32 mg/L). Gentamicin was used as a second marker, due to the very low rate of resistance in the Danish healthy human population. 20 The recipient strain was E. coli K-12 (MG1655); rifampicinresistant (MIC .256 mg/L). It has a human origin. 21 The original E. coli strain K-12 was obtained from a stool sample of a diphtheria patient in Palo Alto, CA, USA, in 1922.
Both donor and recipient strains had a different morphology (the recipient especially had a very distinct one) and were able to grow in different selective plates (Table 1) showing a different resistance profile. In order to confirm the phenotype of the donor and recipient colonies isolated from each volunteer's faecal sample, both the morphology and their ability to grow in the selective plates were investigated.
Media
The selective plates used to count in vitro transconjugants were: (i) LB agar (Sigma-Aldrich, Denmark A/S) added sulfamethizole (1024 mg/L), gentamicin (8 mg/L) and rifampicin (50 mg/L); (ii) sulfamethizole (1024 mg/L) and rifampicin (50 mg/L); and (iii) gentamicin (8 mg/L) and rifampicin (50 mg/L) (suppliers in Table 1 ). The plates were incubated at 358C for 24 h, and the colonies were counted. Selected transconjugants were frozen at 2408C in 10% glycerol for further investigation. The selective plates used for the in vivo study are displayed in Table 1 . Discovery agar is an agar that incorporates a chromogenic medium enabling detection of E. coli by colonies displaying a salmon red colour.
In vitro matings
In vitro matings were performed to investigate transferability of the resistance genes sul2 and aac(3)-IV, encoding sulphonamide and gentamicin resistance, respectively, between the donor and recipient strains. Broth mating experiments were performed as follows: donor and recipient strains from blood agar plates were suspended in 5 mL of 0.9% saline until OD (546 nm) of 0.13 (¼10 8 cfu/mL). To 8 mL of pre-warmed LB broth, we added 800 mL of the recipient solution and 80 mL of the donor solution (ratio 10:1). The culture was incubated for 4 h at 378C and shaken (200 rpm). Serial dilutions of the mixed culture were made until 10 26 in 0.9% saline. From the undiluted and the six dilutions, we performed cfu counting (double measurements). All were done in triple replicas and the mating experiments were repeated twice.
Preparation and ingestion of E. coli suspensions E. coli suspensions of donor and recipient were prepared as follows. The strains were grown overnight at 358C on 5% blood agar (SSI Diagnostica, Hillerød, Denmark). A suspension of the recipient strain was prepared to reach an OD (546 nm) of 1.0 in 0.9% saline equivalent to 10 9 cfu/mL; 1 mL of this suspension was added to 250 mL of pasteurized whole milk to obtain a total count of 10 9 bacteria in 250 mL of whole milk, which was immediately ingested by each volunteer. Three hours later, a suspension of the donor strain was prepared in 0.9% saline until it reached an OD (546 nm) of 0.15 (¼10 8 cfu/mL). Donor suspension (100 mL) was added to 250 mL of milk to obtain a total count of 10 7 bacteria, immediately after it was ingested by each volunteer. All bacterial concentrations were later confirmed by serial dilutions with colony counts of the saline and milk suspensions.
Collection and culture of stool samples
Stool samples were collected from the subjects 24 h prior to the ingestion of the E. coli suspensions (day 0), daily during the following 7 days (days 1-7) and on days 14 and 35. From each stool sample, 1 g was homogenized in 10 mL of 0.9% saline. Serial dilutions were made for cfu calculation with 20 mL spots, and 0.5 mL of the undiluted sample was spread onto 16 cm diameter selective plates (Table 1) . Plates were incubated at 358C for 1 day and counted. All possible transconjugants were stored at 2408C in 10% glycerol for further analysis. The minimal detection level on the plates was 1 cfu/g of faeces.
Antimicrobial susceptibility testing
Two E. coli isolates from each volunteer from day 0, the donor, the recipient and the transconjugant strains were tested for susceptibility to several antimicrobial agents using a commercially prepared, dehydrated panel (Sensititre, Trek Diagnostic, UK). The antimicrobial agents tested were sulfamethoxazole (64 -1024 mg/L), gentamicin (1-32 mg/L) and ampicillin (1-32 mg/L). Susceptibility to rifampicin was tested by Etest (AB BIODISK North America Inc., USA). The E. coli strain ATCC 25922 was used as a quality control for validation of the MIC.
PCR and sequencing
A DNA template of the E. coli was made by adding a pair of colonies to 300 mL of distilled water. The tube was heated for 10 min at 1008C and centrifuged for 5 min at 20 000 g. An aliquot of 2 mL of the supernatant was used as a template. The transconjugant was tested for the presence of sul2 with the following primers designed from the sul2 gene with GenBank accession no. M36657: Sul2-F: 5 0 -TTT CGG CAT CGT CAA CAT AA-3 0 (start position at 21) and Sul2-R: 5 0 -GTG TGT GCG GAT GAA GTC AG-3 0 (start position at 747). The multiplex PCR kit from Qiagen (Ballerup, Denmark) was used with the following amplification conditions: heating for 15 min at 948C, followed by 30 cycles at 948C for 30 s, 488C for 90 s and 728C for 90 s, followed by 728C for 10 min. E. coli NCTC 50020 was used as positive control and E. coli DH5-a plasmid pUVP4401 as negative control. 6 For the amplification of bla TEM , the following primers, obtained from GenBank accession no. AF309824, were used: bla TEM -F, 5 0 -GTA TCC GCT CAT GAG ACA ATA ACC CTG-3 0 and bla TEM -R, 5 0 -CCA ATG CTT AAT CAG TGA GGC ACC-3 0 . 22 The amplification conditions were 3 min at 948C, 30 cycles of 30 s at 948C, 30 s at 608C and 1 min at 728C, 10 min at 728C and hold at 48C. Klebsiella pneumoniae KP6T was used as positive control and E. coli ATCC 25922 as negative control. 23 The sul2 (727 bp) and bla TEM (918 bp) PCR products were purified using the MiniElute w PCR purification kit (Qiagen) and sequenced at Macrogen (Seoul, Korea). For the bla TEM gene, two extra primers were designed inside the gene for better sequencing quality: bla TEM -m-R (AAA GCG GTT AGC TCC TTC GG) and bla TEM -m-F (TCA CCA GTC ACA GAA AAG CAT CTT AC). These primers were synthesized by Macrogen and used for sequencing. The sequences were analysed with Vector NTI software and compared by multiple alignment (ClustalW) with those of the animal donor or the volunteer's own E. coli, if positive to these genes (only in one volunteer).
PFGE
In order to confirm the cfu counts of the selective plates, PFGE of one colony from each plate and each volunteer was performed every second day to see if the profiles were the same as the original donor and recipient ingested. The One-Day PFGE Standardized Laboratory Protocol for Molecular Subtyping of E. coli O157:H7 from PulseNet was used with the following variation: the restriction enzyme used was SpeI (New England BioLabs, Denmark) (20 U/mL) (5 mL of 10Â buffer 2, 42 mL of sterile water, 1 mL of BSA and b Only used to plate stool samples from one person that contained sulphonamide-resistant E. coli before the start of the experiment. Used on day 1 and 2 when the transconjugant was isolated.
2 mL of SpeI). Only 50 mL of restriction enzyme mixture was added to each tube for incubation. 24 The digested DNA was electrophoresed in a 1% agarose gel in 0.5Â TBE using a CHEF DRIII apparatus (Bio-Rad, Herlev, Denmark). The programme was 4-12 s for the first 8 h and then 15 -25 s for 16 h, at 150 mA. Lambda Ladder PFG Marker NO340 (.50 kb) (New England BioLabs) was used as a molecular size marker.
Plasmid profiles
Small-scale preparations of purified E. coli plasmid DNA were performed using the High Pure Plasmid Isolation Kit (Roche Diagnostics, Mannheim, Germany). Purified plasmids were run in a 1% electrophoresis gel together with E. coli V517 and 39R861 used as size markers. V517 has eight plasmids (54, 7.2, 5.6, 5.1, 4.4, 3.0, 2.7 and 2.0 kb) and 39R861 has four (147, 63, 36 and 7 kb). 25, 26 Southern blot hybridization of the sul2 gene Plasmid DNA was transferred to a nylon membrane (Hybond-N filter, Amersham Biosciences, UK). 27 A digoxigenin (DIG)-labelled DNA probe for sul2 was prepared by PCR amplification, using primers and conditions reported by Kerrn et al., 6 and the PCR DIG Probe Synthesis Kit (Roche Diagnostics). Hybridization was carried out at 648C and detection was performed using the DIG Wash and Block Buffer Set (Roche Diagnostics). 27 
Results
Colonization by the E. coli of animal origin
The variations of the concentrations of the donor and recipient strains in faeces during the study are shown in Figure 1 . Prior to the study (day 0), the volunteers were not colonized with sulphonamide-resistant E. coli (except for the volunteer marked in red in Figure 1 ).
The animal donor strain colonized the gut of the volunteers for more than 2 weeks but ,1 month, and reached a maximum of 1.4 Â 10 4 -2.1 Â 10 8 cfu/g faeces on days 1-6, depending on the subject. The human recipient strain was detected for up to a maximum of 7 days (the majority were not shed in the faeces after day 5). It reached a maximum of 2.1 Â 10 2 -7.5 Â 10 6 cfu/g faeces on day 1 or 2 (only one subject on day 6). At the end of the study (day 35), no sulphonamide-resistant E. coli were detected in the stools of any volunteer (Figure 1) . One of the volunteers did not shed the donor and recipient strains after their ingestion, and they appear as zero in both graphs.
Transfer of resistance
In vitro broth mating showed that sul2 transferred easily from the pig-derived E. coli strain to the human recipient with a mean transfer rate of 1 Â 10 22 transconjugants/recipient. Transfer of the sul2 gene to the recipient strain occurred at detectable levels in the intestines of one volunteer (Figure 1) . A transconjugant was recovered on day 2. This subject already had sulphonamideresistant E. coli in the gut before the start of the experiment. The transfer rate found was 5 Â 10 26 transconjugants/recipient. There was also a co-transfer of the bla TEM-1c gene encoding ampicillin resistance.
Since gentamicin and sulfamethizole did not co-transfer in vivo as in vitro, we tried to see if the gentamicin resistance gene aac(3)-IV would transfer alone in the intestines of three human volunteers. No transfer was detected (data not shown).
Confirmation of the transconjugant
Antimicrobial susceptibility testing showed that the transconjugant was resistant to sulfamethoxazole (MIC .1024 mg/L). The presence of the sul2 gene was confirmed by PCR. The transconjugant was also resistant to ampicillin (MIC .32 mg/L), and the presence of the bla TEM-1c gene was confirmed by PCR. Sequences of both genes (sul2 and bla TEM-1c ) were compared with those from the animal donor and the volunteer's own sulphonamide-resistant E. coli. The sul2 and bla TEM-1c genes in the transconjugant showed 100% identity to the genes from the volunteer's own E. coli from day 0. Both genes differed in 1 bp from those of the animal donor. PFGE typing of the in vivo and in vitro transconjugants showed the same profile as the recipient. Furthermore, after comparing the plasmids profiles, the volunteer's resident E. coli donor and the transconjugant contained a plasmid of the same size (.63 kb) (Figure 2a) . The sul2 gene was localized on that plasmid (Figure 2b ). This demonstrates that a plasmid bigger than 63 kb containing the sul2 gene was transferred from an E. coli of the volunteer's own flora to the recipient.
Discussion
This study shows that resistance genes can transfer among E. coli residing in the human intestines. The sul2 gene was transferred together with bla TEM-1c gene coding for ampicillin resistance. This indicates that co-transfer of several resistance genes at the same time is possible. The transfer most probably occurred from this person's own E. coli to the recipient, due to the same identity of both genes sul2 and bla TEM-1c from the resident and transconjugant strains.
In the volunteer where the transfer took place on day 2, both the resident and recipient strains reached high concentrations (. 10 6 cfu/g). This suggests that in order for the transfer to occur, high numbers of both donor and recipient should coincide at the same time in the gut, as suggested in previous observations. 28 Our study was carried out without any selective pressure and the duration of colonization and transfer frequency would probably have been increased with the administration of antimicrobial agents. In support of this assumption, Anderson et al. 29 did not obtain R-factor transfer in the absence of chemotherapy in four subjects. On the contrary, they proved R-factor transfer in the gut of three subjects when a 5 day course treatment with antibiotic was applied after ingestion of donor and recipient suspensions. We did not do this because of the ethical implications. In vitro transfer results cannot be directly extrapolated to the in vivo situation. In this study, the in vitro transfer rate was higher than the in vivo rate, but there are several explanations for this, e.g. the competitive flora of the gut, lack of selective pressure and less chances for donor and recipient to meet. Netherwood et al. 30 showed that in vitro methods, such as forced filter mating and liquid mating, underestimate the in vivo rates of gene transfer. The methods used to detect transfer in vivo have severe sensitivity limitations and tend to underestimate the true rate of transfer in vivo.
In the present study, the volunteer in whom the transfer took place was colonized by sulphonamide-resistant E. coli and was positive for the sul2 gene before the start of the experiment. The sul2 gene in the animal donor strain differed from the transconjugant by a mutation to T instead of a G at position 672 (data not shown). The type detected in the transconjugant has previously been associated mainly with poultry isolates based on a sequence comparison of isolates from different sources (M. Trobos, H. Christensen, M. Sunde, S. Nordentoft, Y. Agersø, G. S. Simonsen, A. M. Hammerum and J. E. Olsen, unpublished results). The association is made possible by the fact that the sul2 gene is conserved with mainly two varying positions. The volunteer had a mostly vegetarian diet, eating chicken only sporadically. Since the transconjugant had the sul2 sequence found mostly among chicken, a chicken origin of the E. coli is likely, but it cannot be ruled out that other sources for this sequence type have remained undiscovered.
Linton et al. 31 studied whether resistant E. coli strains from commercially purchased chickens were transferred and established as part of the flora of human consumers. One of five volunteers became colonized by five of the 14 resistant E. coli strains found in one chicken after thawing. The strains stayed in the faecal flora for 10 days. A resistant faecal normal flora in meat-producing animals may thus have an impact on the resistance of the normal flora of human consumers. In a study by Johnson et al., 32 molecular typing methods matched four turkeysource isolates to selected human clinical and faecal isolates representing the clonal group A of extra-intestinal pathogenic E. coli (ExPEC). Meats purchased in grocery stores, particularly turkey products, were frequently contaminated with antimicrobialresistant E. coli and ExPEC.
Smith 15 concluded that E. coli strains of animal origin were poorer colonizers than strains of human origin. In this study, we showed the opposite, that the strain of animal origin was more persistent in the gut than the human strain. A possible explanation could be that our recipient strain, E. coli K12, has been cultivated in the laboratory for so long that it has lost the ability to colonize humans. 33 The poor survival of the recipient strain might have been the reason why transfer was low. This corresponds to previous survival studies of E. coli K12 where it only survived for few days (maximum six) in the human intestine, but was ultimately eliminated. 34, 35 In these two studies, they could, however, transfer hybrid plasmids from E. coli K12 to the resident E. coli.
In addition, the strain of animal origin reached higher numbers in the gut, even though it was administered in 100-fold lower numbers than the recipient. This was done because we wanted to mimic the situation of healthy humans eating meat containing sulphonamide-resistant E. coli and see for how long they would colonize the gut. If the strain had persisted for more than 2 weeks after one ingestion only, we could expect a longer persistence in the gut when people consume meat several times per week. This would provide a continuous flow of resistance genes that could transfer to the human indigenous flora.
One of the volunteers did not shed the donor and recipient strains after their ingestion, and they appear as zero in Figures 1  and 2 . A possible explanation could be that this person did not ingest enough food with the bacterial suspensions and the gastric acids killed them, or they were at a competitive disadvantage with the indigenous flora.
To investigate how well our recipient strain colonized, we performed a pilot study where three human volunteers ingested only the recipient strain. It colonized for a period of 3 -5 days (data not shown). Furthermore, during the follow-up of these three volunteers, in one person at days 3 and 35, E. coli resistant to tetracycline from his own flora were detected (6 Â 10 cfu/g and 10 2 cfu/g, respectively), while another person contained .5 Â 10 3 cfu/g E. coli resistant to tetracycline, and to both sulphonamide and gentamicin ($10 7 cfu/g) on days 14 and 35. E. coli resistant to these antibiotics were below the detection level at the start of the experiment. This underlines that E. coli of unknown origin (food, animals or environment), which colonize the gut for specific days may represent a pool of resistance genes that might transfer to other E. coli of the gut flora. It seems that the stability of the E. coli intestinal flora is dependent on what is swallowed. In 1970, Cooke et al. 36 found 63 samples of food out of 873 containing E. coli numbers between 25 and 10 4 cfu/g in a hospital. An identical faecal serotype of E. coli from food and five patients was isolated. All the serotypes found in the food and in the patients were also isolated from meat and poultry on or before its arrival in the hospital.
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Even with the low concentration of the recipient strain in the volunteers' gut in the current study, a transconjugant was detected. There would be a higher possibility of transfer to the resident E. coli (10 6 -10 7 cfu/mL) that are present in the human gut. If food containing a resistant bacterial strain is ingested in sufficient amounts, and the strain is able to colonize the human gut, we have demonstrated the possibility of transfer of resistance genes to the resident bacteria in the intestinal flora. However, studies with larger numbers of individuals are required to ascertain the actual transmission rate between resistant animal donor strains and resident recipient flora.
